and predicting new inhibitors or precursors for a certain application. However, data is quite scarce in AS-ALD and the approach has not been shown to be useful yet. For ALD, the current state-ofthe-art is summarized in a recent book. As outlined above, classical approaches for nucleation modeling are not discussed here since they have not been connected to ab initio modeling results. 4 Challenges and perspectives